A Community-based Study on Prevalence and

Table of contents

1.

Plain English Summary-Erectile dysfunction (ED) is defined as persistent inability to attain and/or maintain an erection sufficient for satisfactory sexual activity. ED is associated with old age and comorbidities including diabetes and hypertension amongst others. The incidence of ED is increasing globally and this is attributed to the aging population and the increase in the incidence of diabetes and hypertension.

We aimed to determine the burden of ED among male residents of Kinondoni district, Dar es Salaam Tanzania. We recruited and interviewed 441 men aged at least 18 years. We utilized the 5-item version of the International Index of Erectile Function (IIEF-5) Scale for erectile dysfunction assessment. We defined diabetes and hypertension according to the International Diabetes Federation and the 7th Report of the Joint National Committee (JNC 7) respectively.

About a quarter of all men had some form of ED. Old age and diabetes were associated with a 5 times increased likelihood for having ED. We concluded that ED is a common problem among men of reproductive age and that in view of this, men with diabetes and hypertension should be offered screening services and treatment of ED as an integral component in their management.

2. I. Background

rectile dysfunction (ED) is defined as persistent inability to attain and/or maintain an erection sufficient for satisfactory sexual activity. 1 Despite its benign nature, ED has the potential to impair personal interactions, quality of life and well-being of both patients and their partners. [2][3][4] The rates of ED increase with age almost always indicating endothelial dysfunction. [5][6][7][8][9][10][11][12][13][14] Furthermore, ED is associated with a number of medical conditions or their treatment including diabetes mellitus, hypertension, coronary artery disease and depression. [15][16][17][18][19][20][21][22] Establishing the burden of ED in the community is challenging and most clinicians lack adequate skills in detecting and/or managing it. 23,24 The reported rates worldwide have a wide variability ranging between 2% and 90% depending on the age, race, comorbidities, hospital-versus community-based, assessment tool, and geographical location of the population studied. 8,12,[25][26][27][28][29][30][31][32][33][34][35][36][37][38][39][40] With the rising of comorbidities associated with ED worldwide, it is projected that its incidence will rise appreciably and that by year 2025, 332 million men will have some form of ED. 41 To elucidate on the prevalence of ED and its associated factors in a Tanzanian community we undertook this cross-sectional study among Kinondoni district men.

3. II. Methods a) Study Procedures & Definition of Terms

We conducted this community-based crosssectional screening among men residing in Kinondoni district, Dar es Salaam, Tanzania in January 2016. 441 men of African descent aged at least 18 years were recruited and screened for erectile dysfunction. Participants were consented to participate in the study after they voluntarily came to the screening grounds for an organized general health check-up. Interviewers, mainly clinicians and nurses from the Jakaya Kikwete Cardiac Institute (JKCI) and Mwananyamala District Hospital were recruited and trained to administer the questionnaire and perform anthropometric, blood pressure (BP) and random/fasting blood glucose (RBG/ FBG) measurements. Weight and height were measured with standard scales and BMI was calculated by a ratio of weight (in kilograms) to height (in meters) squared. WHO BMI cut-off values were used to define underweight, normal, overweight and obese. 42 Smoking history was sought and participants were categorized as current, past or a never smoker. Diabetes was diagnosed using RBG ?11.1 mmol/L and/or FBG ?7 mmol/L. 43 Prediabetes was defined as FBG of 5.6-6.9 mmol/L and/or RBG of 7.8-11.0 mmol/L. 43 Blood pressure was measured by digital BP machines where a systolic blood pressure (SBP) <120 mmHg and a diastolic blood pressure (DBP) <80 mmHg defined normotension. Pre-hypertension was defined by SBP of 120-139 mmHg or DBP of 80-89 mmHg, while SBP ?140 mmHg or DBP ?90 mmHg indicated hypertension. 44 The 5-item version of the International Index of Erectile Function (IIEF-5) Scale was used to assess for erectile dysfunction. [45][46][47][48]

4. b) Statistical analysis

Continuous variables are summarized and presented as means (± SD) while categorical variables are displayed as frequencies (percentages). Chi square tests and Student's T-test were used in comparison of categorical and continuous variables respectively. Bivariate analyses were performed to determine factors associated with ED. Significant factors on bivariate analysis were included in a logistic regression model to control for confounders. Odd ratios with 95% confidence intervals and p-values are reported. STATA v.11.0 was used for analysis, significance was set at p<0.05 and all analyses were two-sided.

5. III. Results

Socio-demographic and clinical characteristics of 441 study participants is displayed in Table 1. The mean age was 47.1 (±15.4) years and 63.7% were aged 40 years and above. 53.8% had completed primary school, 71% were married, and 14% ever smoked. The mean BMI was 26.6 (±5.3) kg/m 2 and 57.6% of individuals had excess body weight (i.e. BMI ?25). The mean blood glucose level was 6.1 (±2.2) mmol/L and 8.2% had diabetes. The mean SBP and DBP were 146 (±32) mmHg and 91 (±20) mmHg respectively and 61.5% had hypertension.

Overall, 24% (106/441) of men in this study had some form of ED. Prevalence of ED increased with increase in age and weight i.e. 37% and 32% of those aged ?55 and obese respectively had ED compared to 10.6% and 18.1% among those aged 18-39 years and normal BMI, (p <0.001 and p<0.01 respectively), Figure 1. Men with a positive smoking history had a 40% increased likelihood for ED compared to never smokers, (OR 1.4, 95%CI 0.7-2.5, p>0.05). 63% of men with diabetes had ED compared to 30.4% with prediabetes and 19.1% with normal blood glucose, (p<0.01 and p<0.001 respectively). Participants with prehypertension (20.2%) and hypertension (29.3%) had significantly higher ED rates compared to normotensive persons (8.3%), p<0.05 and p<0.001 respectively.

Six variables including age, BMI, physical activity, smoking, hypertension, and diabetes status underwent bivariate analyses to assess if they have associations with ED. Four variables including age, BMI, hypertension and diabetes status revealed significant associations and these were added in a logistic regression model for further analysis. Table 2 displays results of multivariate logistic regression analysis. Men aged 40 years and above displayed a 5 times increased likelihood of having ED compared to those younger than 40 years, (OR 5.0, 95% CI 2.2-11.2, p<0.001). Likewise, diabetes was associated with a 5 times increased odds of having ED, (OR 5.3, 95% CI 2.2-12.7, p<0.001).

6. IV. Discussion

Nearly a quarter of men in this present study had ED. Our findings are close to a Chinese study by Bai et al which produced a prevalence of 28.3%. 49 A wide variability in the prevalence of ED from 13.2% 50 in Egypt to 51.3 25 in Singapore observed among studies 12,25,42,51 is largely a result of variabilities in population characteristics and tools used for ED assessment among studies. Old age has been consistently shown to be a strong predictor of ED. 25 In this study, the rate of ED among participants aged 55 and above was 3 times compared to those in the age group 18-39 years. These findings echo the results of a landmark Massachusetts Male Aging Study 25 among others. 2,18,30 Aging is associated with comorbidities resulting into atherosclerosis and ultimately vascular dysfunction with ED as one of the manifestations. 52 Obesity was significantly associated with ED on bivariate analyses in this study. Such findings are in unison with Moreira 12 et al study in which obesity proved to be a significant predictor on bivariate analysis but lost its significance after multivariate analysis. A study by Chung et al 53 showed that obesity is not an underlying factor for ED per se, but it does increase the risk through development of chronic vascular disease. Numerous studies 12,52,[54][55][56][57] have suggested a dose dependent relationship between smoking and ED. Ever smokers in this study had a 40% increased likelihood for ED compared to never smokers. A systematic review by Cao 57 et al found that ED was increased by 20% and 51% among past-and current-smokers respectively. Apart from its potential to cause direct toxic effects on the vascular endothelium, smoking is linked to ED through its potential to mediate systemic changes including hypercoagulability, platelet aggregation and thromboxane-prostacyclin imbalance. 58 Diabetes is a well-established factor for ED. Participants with diabetes in our study had a 5 times increased odds for ED (OR 5.3) compared to diabetesfree persons. These current results have replicated the findings of a study by Zedan 59 et al among Egyptian men which found an odds of 5.4. Other studies have consistently produced higher ED rates among diabetics compared to diabetes-free persons ranging between 35% and 75%. 8,11,12,25,41,[60][61][62][63][64][65] Diabetes is a risk factor for ED through its potential for causing autonomic neuropathy, gonadal dysfunction, and vascular and neurogenic impairment of penile smooth muscle. 61,66,67 Hypertensive participants had a tripled likelihood of having ED compared to their normotensive counterparts (p<0.001), however the significance was lost after multivariate logistic analyses. Hypertension and some antihypertensive drugs have been shown to increase the risk for ED. 17,30,35,68 High blood pressure is known to interfere with blood flow to the corpora cavernosa by causing narrowing and loss of elasticity of arteries thus resulting to ED. 69 Other factors including heavy alcohol consumption, 2,54,70 depression, 18,[71][72][73] and low economic status 18,74,75 have been associated with increased risk for ED but were beyond the scope of this study. Further studies on ED in this area could investigate on their association with ED among Tanzanian men.

This study has several strengths including; (i) the use of an internationally recognized tool for assessing ED that will make comparison with other studies feasible, (ii) the simultaneous assessment of obesity, diabetes and hypertension allowed us to confirm the presence of these risk factors rather than relying on participants' self-report. This study has some limitations as well, including; (i) the generalizability of our findings may be limited because the men screened in this study voluntarily came for screening and this might reflect a selected population of those either with a very good health seeking behavior or those having some health concerns necessitating medical help, (ii) Our assessment of ED was through interviews and we are aware that conditions like ED are highly associated with social stigmas. As a result of this, it is likely that ED was underreported by study participants, (iii) we made diagnoses of hypertension and diabetes based on a single point measurement of BP and RBG/FBG, thus our diabetes and hypertension rates might be overestimated, and (iv) our study was prone to several forms of bias including selection bias and nondifferential bias, inevitably due to its cross-sectional nature.

7. V. Conclusions

Several conclusions can be drawn from this present study: (i) ED affects one in four men over 18 years in urban Tanzania, (ii) age and diabetes mellitus are the strongest factors associated with ED, (iii) the high rates of ED among hypertensive and diabetic patients suggest that patients with such comorbidities should be screened for ED, (iv) with the increasing incidence of obesity, hypertension, diabetes and an aging population, ED may become a significant public health problem. In view of these findings: (i) services for diagnosis and treatment of ED should be readily available to men in developing nations, and (ii) health programs should be designed in developing nations to educate and empower individuals on healthy eating, physical activeness and health seeking behavior.

8. Declarations Ethical Approval and Consent to Participate

Ethical clearance was obtained from the Unit of Research of the Jakaya Kikwete Cardiac Institute (JKCI). Permission to conduct the study was granted by the Office of the Kinondoni District Commissioner. All participating men gave informed consent. manuscript development of this research. The authors assume the responsibility for this work.

9. Authors Contributions

MJ, PK, and PP made contributions in study designing. PP and PN performed all data management and manuscript writing. The initial draft was revised by PK, HM, NS and MJ. All authors contributed to and approved the final manuscript version.

Figure 1. A
Community-based Study on Prevalence and Correlates of Erectile Dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania
Figure 2. Figure 1 :
1Figure 1 : Prevalence of ED by Age, BMI, Diabetes and Hypertension status Tables and Captions
Figure 3. Table 1 :
1
Characteristic n (%)
Age groups
18-39 160 (36.3%)
40-54 135 (30.6%)
?55 146 (33.1%)
Education level
None 12 (02.7%)
Primary 237 (53.8%)
Secondary 139 (31.5%)
University 53 (12.0%)
Marital status
Single 95 (21.6%)
Married 313 (71.0%)
Divorced 24 (05.4%)
Widowed 9 (02.0%)
Smoking status
Non-smoker 379 (86.0%)
Current smoker 9 (02.0%)
Past smoker 53 (12.0%)
BMI status
Underweight 14 (03.2%)
Normal 173 (39.2%)
Overweight 154 (35.0%)
Obese 100 (22.6%)
Blood Sugar Range
Normal 344 (77.9%)
Prediabetes 61 (13.9%)
Diabetes 36 (08.2%)
Blood Pressure Range
Normal 60 (13.6%)
Prehypertension 110 (24.9%)
Hypertension 271 (61.5%)
Figure 4. Table 2 :
2
Test group Comparative group OR 95% CI P-value
Age ?40 Age<40 5.0 2.2-11.2 <0.001
BMI ?30 BMI <30 1.4 0.7-2.5 0.306
Hypertensive Non-hypertensive 1.2 0.6-2.3 0.541
Diabetic Non-diabetic 5.3 2.2-12.7 <0.001
1
2

Appendix A

Appendix A.1

We are grateful to clinicians and nurses of the Jakaya Kikwete Cardiac Institute and Mwananyamala hospital for their dedication towards this study. The authors are indebted to Hon. Regional Commissioner Paul Makonda for the technical and financial support.

Appendix B

Appendix B.1 Availability of Data and Materials

The final version of data set supporting the findings of this paper may be found in the Jakaya Kikwete Cardiac Institute website (www.jkci.or.tz). The corresponding author will be more than willing to email the data set to the editorial committee whenever it's needed.

Appendix B.2 Conflict of interest

The authors declare no conflict of interest to disclose.

Appendix B.3 Funding

This study was funded by the Office of the District Commissioner for Kinondoni Municipal. The funder played no role in the design, analysis and

Appendix C

  1. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. A Al-Hunayan , M Al-Mutar , E O Kehinde , L Thalib , M Al-Ghorory . BJU Int 2007. 99 p. .
  2. The epidemiology of erectile dysfunction and its risk factors. A Bortolotti , F Parazzini , E Colli , M Landoni . Int J Androl 1997. 20 p. .
  3. Erectile dysfunction in the elderly; epidemiology, aetiology and approaches to treatment. A D Seftel . J Urol 2003. 169 (6) p. .
  4. The epidemiology of erectile dysfunction. A E Benet , A Melman . Urol Clin North Am 1995. 22 p. .
  5. Erectile dysfunction risk factors in non-insulin dependent diabetic Saudi patients. A I El-Sakka , K A Tayeb . J Urol 2003. 169 p. .
  6. Prevalence of erectile dysfunction in Thailand. Thai Erectile Dysfunction Epidemiological Study Group. A Kongkanand . Int J Androl 2000. 23 (2) p. .
  7. Prevalence of erectile dysfunction in Thailand. A Kongkanand . Int. J Androl 2000. 23 (2) p. . (Suppl)
  8. Erectile dysfunction in patients with diabetes. Alexander Mh , Wd . Hosp Med dysfunction 1999. 60 p. .
  9. Prevalence and independent risk factors for erectile dysfunction in Spain: results of the Epidemiologia de la Disfuncion Erectil Masculina Study. A Martin-Morales , J J Sanchez-Cruz , T I Saenz . J Urol 2001. 166 p. .
  10. Erectile Dysfunction. A Muneer , J Kalsi , I Nazareth , M Arya . BMJ 2014. 348 p. 129.
  11. seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. A V Chobanian , G L Bakris , H R Black . Hypertension 2003. 42 p. .
  12. Modifiable risk factors and erectile dysfunction: Can lifestyle changes modify risk. C A Derby , B A Mohr , I Goldstein , H A Feldman , C B Johannes , J B Mckinlay . Urology 2000. 56 p. .
  13. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. C B Johannes , A B Araujo , C A Derby . J Urol 2000. 163 (2) p. .
  14. Erectile dysfunction in the community: a prevalence study. C B Pinnock , V R Marshall . Med J Aust 1999. 171 (7) p. .
  15. Erectile dysfunction in the community: a prevalence study. C B Pinnock , A M Stapleton , V R Marshall . Med J Aust 1999. 171 (7) p. .
  16. Classification and diagnosis of diabetes. Sec. 2. In Standards of Medical Care in Diabetes-2015. Diabetes Care 2015. American Diabetes Association. 38 p. . (Suppl. 1)
  17. Quality of Care and Outcomes in Type 2 Diabetes (QuED) Study Group. Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked. De Berardis , G Franciosi , M . Diabetes Care 2002. 25 (2) p. .
  18. Erectile dysfunction in diabetic subjects in Italy. Gruppo Italiano Studio Deficit Erettile nei Diabetici. D Fedele , C Coscelli , F Santeusanio . Diabetes Care 1998. 21 p. .
  19. Erectile dysfunction in type 1 and type 2 diabetics in Italy. On behalf of Gruppo Italiano Studio Deficit Erettile nei Diabetici. D Fedele , A Bortolotti , C Coscelli . Int J Epidemiol 2000. 29 p. .
  20. The prevalence of diabetic impotence. D K Mcculloch , I W Campbell , Wu Fc . Diabetologia 1980. 18 p. .
  21. Cigarette smoking: An independent risk factor for impotence?. D M Mannino , R M Klevens , W D Flanders . Am J Epidemiol 1994. 140 p. .
  22. Prevalence and correlates of erectile dysfunction: results of the Brazilian study of sexual behavior. E D Moreira , C H Abdo , E B Torres . Urology 2001. 58 p. .
  23. Prevalence and determinants of erectile dysfunction in Santos, southeastern Brazil. E D Moreira , W J Bestane , E B Bartolo , Jas Fittipaldi . Sao Paulo Med. J 2002. 120 p. .
  24. Prevalence and risk factors for erectile dysfunction in the US. E Selvin , A L Burnett , E A Platz . Am J Med 2007. 120 (2) p. .
  25. Sexual dysfunction among Jordanian men with diabetes. F A Khatib , Ns , N S Shegem , A M Bateiha , R M Abu-Ali , K M Ajlouni . Saudi Med J 2006. 27 p. .
  26. Impotence in diabetic men. F E Kaiser , S G Korenman . Am J Med 1988. 85 p. .
  27. Aging and pathogenesis of erectile dysfunction. G Corona , E Mannucci , R Mansani . Int J Impot Res 2004. 16 (5) p. .
  28. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. H A Feldman , I Goldstein , Hatzichristou . J Urol 1994. 151 p. .
  29. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. H A Feldman , I Goldstein , D G Hatzichristou . J Urol 1994. 151 (1) p. .
  30. The incidence of sexual dysfunction in patients attending Dutch general practitioners. H Kedde , G Donker , P Leusink , H Kruijer . International Journal of Sexual Health 2011. 23 (4) p. .
  31. Cigarette smoking, hypertension and diabetes mellitus as risk factors for erectile dysfunction in upper Egypt. H Zedan , A A Hareadei , A A Abd-Elsayed , Abdel-Maguid , EM . East Med Health J 2010. 16 p. .
  32. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. I A Ayta , J B Mckinlay , R J Krane . BJU Int 1999. 84 (1) p. .
  33. , Impotence . JAMA 1993. 270 p. .
  34. Impaired neurogenic and endotheliummediated relaxation of penile smooth muscle from diabetic men with impotence. I Saenz De Tejada , I Goldstein , K Azadzoi , R J Krane , R A Cohen . N Engl J Med 1989. 320 p. .
  35. Diabetic penile neuropathy. I Sáenz De Tejada , I Goldstein . Urol Clin North Am 1988. 15 (1) p. .
  36. Pathophysiology of erectile dysfunction. I Sáenz De Tejada , J Angulo , S Cellek . J Sex Med 2005. 2 (1) p. .
  37. The questionable physiologic and epidemiologic bases for a male climacteric syndrome: preliminary results from Massachusetts Male Aging Study. J B Mckinlay , C Longcope , A Gary . Maturitas 1989. 11 p. .
  38. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. J C Cappelleri , R C Rosen , M D Smith . Urology 1999. 54 p. .
  39. Effect of erectile dysfunction on frequency of intercourse: a population based prevalence study in Finland. J Koskimaki , M Hakama , H Huhtala , T L Tammela . J Urol 2000. 164 p. .
  40. Erectile Dysfunction in Singapore: Prevalence and Its Associated Factors -A Population-Based Study. J K Tan , C Y Hong , Djc Png , Lch Liew , M L Wong . Singapore Med J 2003. 44 (1) p. .
  41. Prevalence of erectile dysfunction: a systematic review of population-based studies. J Prins , M H Blanker , A M Bohnen , S Thomas , Jlhr Bosch . International Journal of Impotence Research 2002. 14 p. .
  42. Erectile dysfunction in general medicine practice: prevalence and clinical correlates. K K Chew , C M Earle , B G Stuckey . Int J Impot Res 2000. 12 p. .
  43. Sexual problems: a study of the prevalence and need for health care in the general population. K M Dunn , P R Croft , G I Hackett . Fam Pract 1998. 15 p. .
  44. Subcommittee on Smoking and Erectile Dysfunction Socioeconomic Committee, Sexual Medicine Society of North America. Smoking and erectile dysfunction: evidence based analysis. K T Mcvary , S Carrier , H Wessells . J Urol 2001. 166 p. .
  45. Prevalence and Correlates of Erectile Dysfunction among Primary Care Clinic Attendees in Nigeria. L A Adebusoye , O E Olapade-Olaopa , M M Ladipo , E T Owoaje . Global Journal of Health Science 2012. 4 (4) p. .
  46. Epidemiology of erectile dysfunction: results of the "Cologne Male Survey. M Braun , G Wassmer , T Klotz . Int J Impot Res 2000. 12 p. .
  47. Epidemiology of erectile dysfunction: results of the 'Cologne Male Survey'. M Braun , G Wassmer , G Klotz . Int J Impot Res 2000. 12 p. .
  48. Hypertension, erectile dysfunction, and occult sleep apnea. M Hirshkowitz , I Karacan , A Gurakar . Sleep 1989. 12 p. .
  49. Vascular factor in erectile failure among diabetics. M J Jevtich , M Edson , W D Jarman , H H Herrera . Urology 1982. 19 p. .
  50. Diabetes and vascular impotence: does insulin dependence increase the relative severity?. M J Metro , G A Broderick . Int J Impot Res 1999. 11 p. .
  51. Epidemiology of erectile dysfunction. M Kubin , G Wagner , A R Fugl-Meyer . Int J Impot Res 2003. 15 (1) p. .
  52. Smoking and vascular impotence: A reason for concern. M S Bornman , D J Du Plessis . S Afr Med J 1986. 70 p. .
  53. Total cholesterol and high density lipoprotein cholesterol as important predictors of erectile dysfunction. M Wei , C A Macera , D R Davis . Am J Epidemiol 1994. 140 p. .
  54. Multifactorial evaluation of diabetic erectile dysfunction. O Kayigil , O Atahan , A Metin . Int Urol Nephrol 1996. 28 p. .
  55. Physical status: the use and interpretation of anthropometry. WHO Technical Report Series 1995. World Health Organization. 854. (WHO)
  56. Prevalence and risk factors of erectile dysfunction in three cities of China: a community-based study. Q Bai , Q Xu , H Jiang , W Zhang , X Wang , J Zhu . Asian J Androl 2004 Dec. 6 p. .
  57. Sexual dysfunction in diabetic men. R C Kolodny , C B Kahn , H H Goldstein , D M Bornett . Diabetes 1974. 13 (4) p. .
  58. Brief male sexual function inventory for urology. R C Rosen . Urology 1996. 47 (5) p. .
  59. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. R C Rosen , A Riley , G Wagner . Urology 1997. 49 (7) p. .
  60. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. R C Rosen , J C Cappelleri , M D Smith . Int J Impot Res 1999. 11 p. .
  61. The sexual health inventory for men (IIEF-5). R C Rosen , J C Cappelleri . Int J Impot Res 2000. 12 p. .
  62. , R J Krane , I Goldstein , I Saenz De Tejada , Impotence . N Engl J Med 1989. 321 p. .
  63. Erectile dysfunction, R Kirby , S Holmes , C Carson . 1998. Oxford: Health Press. (2nd ed)
  64. Prevalence of selfreported erectile dysfunction in people with longterm IDDM. R Klein , B E Klein , K E Lee . Diabetes Care 1996. 19 p. .
  65. Prevalence of erectile dysfunction and associated factors among diabetic men attending diabetic clinic at Muhimbili National Hospital in Dar-es-Salaam. R K Mutagaywa , J Lutale , M Aboud , B A Kamala . Tanzania. The Pan African Medical Journal 2014. 17 p. 227.
  66. The effect of erectile dysfunction on quality of life: psychometric testing of a new quality of life measure for patients with erectile dysfunction. R Macdonagh , P Ewings , T Porter . J Urol 2002. 167 (1) p. .
  67. Prevalence of erectile dysfunction and its correlates in Egypt: a community-based study. R M Seyam , A Albakry , A Ghobish , H Arif , K Dandash , H Rashwan . Int J Impot Res 2003. 15 p. .
  68. Epidemiology/risk factors of sexual dysfunction. R W Lewis , K S Fugl-Meyer , R Bosch . J Sex Med 2004. 1 (1) p. .
  69. Prevalence of erectile dysfunction and its correlates: a population based study in Morocco. S Berrada , N Kadri , S Mechakra-Tahari , C Nejjari . Int J Impot Res 2003. 15 (1) p. . (Suppl)
  70. Smoking and Risk of Erectile Dysfunction: Systematic Review of Observational Studies with Meta-Analysis. S Cao , X Yin , Y Wang , H Zhou , F Song , Z Lu . PLoS One 2013. 8 (4) p. e60443.
  71. Prevalence of and risk for erectile dysfunction in Hong Kong patients. S C Siu , S K Lo , K W Wong . Diabetes Med 2001. 18 p. .
  72. Sex and the quality of life in Denmark. S Ventegodt . Arch Sex Behav 1998. 27 p. .
  73. Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. T Y Ahn , J K Park , S W Lee . Int J Sex Med 2007. 4 (5) p. .
  74. The prevalence of erectile dysfunction at a primary healthcare clinic in Durban. Y Lockhat , A Ross , P Ramlachan , C Rangiah . South African Family Practice 55 (3) p. .
Notes
1
© 2016 Global Journals Inc. (US)
2
A Community-based Study on Prevalence and Correlates of Erectile Dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania
Home 
Date: 2016-01-15